Becton Dickinson and Company Limited

Other

Richard L Moore

James A Garrett

Robert W Rosenstein

Nicholas Robert Bachur, Jr

Sha-Sha Wang

James G Nadeau

Leroy E Hood

Robert Lovejoy Goodwin

Stanley B Prusiner

Bradley Jeffery Behm

Kenneth Paul Kiraly

Michael A Brasch

Song Shi

John Lattyak

Gregg Elliott Zehr

Alexander George Lastovich

Keith Edward Thornton

Gregory Tice

William E Keating

Brandon John Smith

Beryl Tomay

Thomas A Ryan

Daniel Lee Schwarz

William Kevin Carpenter

Michael V Rykov

James C Slezak

Thomas M Gentle

Owen Lewis Joyce

Aviram Zagorie

Kevin R Cheung

Joshua Herr

Kristin Weidemaier

Perry D Haaland

Qihua Xu

Eric Fallows

Donald W Copertino

William A Nussbaumer

David S Sebba

Thomas M Gentle, Jr

Craig C Whiteford

Paul Ernest Goldenbaum

Michael L Towns

Tim Tan

Jon E Salomon

Richard Ivey

Elizabeth J Want

Miroslaw Bartkowiak

Richard Abbot

Ajay M Desai

David Westaway

Alexander Adam Papp

Cristian Clavijo

Zhouxin Shen

Gary Siuzdak

Brent Eric Wood

Christopher M Embres

Jon Saxton

Inyoul Lee

Paula V Johnson

Sean Connell

Harry Yang

Patrick Tremblay

Shirley Ng

Girish Bajaj

Thomas M Fruchterman

Neil C Roseman

Xiaotian Guo

Meghan Wolfgang

Thomas Gentle

Methods for predicting the development of sepsis in a subject at risk for developing sepsis are provided. In one method, features in a biomarker profile of the subject are evaluated. The subject is likely to develop sepsis if these features satisfy a particular value set. Methods for predicting the development of a stage of sepsis in a subject at risk for developing a stage of sepsis are provided. In one method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to have the stage of sepsis if these feature values satisfy a particular value set. Methods of diagnosing sepsis in a subject are provided. In one such method, a plurality of features in a biomarker profile of the subject is evaluated. The subject is likely to develop sepsis when the plurality of features satisfies a particular value set.

Diagnosis of sepsis

The present invention relates to methods, monitors and systems, useful, for example, for advanced detection of sepsis in a subject.

Advanced detection of sepsis

An Avocado Skinning and Pulping Device. The avocado pulper has two grip belts approximately oval in shape and further having a plurality of grip plates around the grip belts. The grip plates are knurled thereby facilitating a grasping of an avocado as it is conveyed into the grip belts and rides through to the rear opening. A pivotable and adjustable belt guide within an inner section of each grip belt is adapted to exert maximum squeezing pressure on the avocado at the approximate middle section of the grip belts at which point the grip belts are in approximate contact with one another. Pulp is thereby squeezed from the avocado. The grip belts separate at the approximate rear defining space for releasing the skin of the avocado. A de-seeder adjacent to the front end opening of the grip belts removes the seed from the avocado prior to its entry into the maximum squeezing section.

Avocado skinning and pulping device

A sports ball training assembly for repetitively practicing sporting techniques in a small area, such as, hitting a golf ball, kicking a soccer ball, or batting a baseball. A telescoping arm attaches to the ball, extending and retracting to create different positions to strike the ball. A spring attaches to the telescoping arm. The spring has sufficient elasticity to return the ball to equilibrium position after the ball is propelled forward. The elasticity of the spring and the elevation of the ball can be adjusted by enclosing various sections of the spring with a tube that slides along the longitudinal axis of the spring. As the rigid tube moves along the spring, the spring's characteristics change. A second spring portion enhances stability and control of the ball, and allows the ball to return to the user. A base and a base shaft provide structure to the assembly.

Sports ball training assembly

The present invention relates to methods, monitors and systems measuring lysophosphatidylcholine, its derivatives and/or procalcitonin as well as at least one clinical marker (e.g. temperature or respiration rate) and/or at least one biomarker for the early detection of sepsis in a subject.

Systems and methods for calculating an initial amount of target nucleic acid Nin a sample are provided. A plurality of fluorescent measurements is received. Each respective fluorescent measurement FSis taken in a different cycle n in a PCR amplification experiment of the sample. Then, a model for the PCR amplification experiment is computed. For each respective fluorescent measurement, the model comprises a respective equation for N, where (i) Nis the calculated amount of the target nucleic acid in cycle n of the corresponding PCR amplification experiment, and (ii) the equation for Nis expressed in terms of K and N, where K is the Michaelis-Menton constant. The model can be refined by adjusting K and Nuntil differences between model values Nand corresponding fluorescent measurements are minimized, thereby calculating the initial amount of a target nucleic acid Nas the minimized value for Nfor the model.

Systems and methods for determining an amount of starting reagent using the polymerase chain reaction

The present invention provides methods and compositions useful for the diagnosis or prognosis of a systemic inflammatory condition such as sepsis.

Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition

An avocado de-skinning apparatus having two generally vertically disposed rotating drums. The rotating drums rotate inward to pinch the skin of an avocado and force the off and through a gap defined between the rotating drums. A driver in the gap and in the upper section of the rotating drums aids in forcing the skin from the avocado and into the gap and through the rear side of the rotating drums. A skin scraper removes any skin adhering to the drums and a pulp scraper retrieves any pulp adhering to the drums for further processing.

Avocado de-skinning apparatus

The early prediction or diagnosis of sepsis advantageously allows for clinical intervention before the disease rapidly progresses beyond initial stages to the more severe stages, such as severe sepsis or septic shock, which are associated with high mortality. Early prediction or diagnosis is accomplished using a molecular diagnostics approach, involving comparing an individual's profile of biomarker expression to profiles obtained from one or more control, or reference, populations, which may include a population who develops sepsis. Recognition of features in the individual's biomarker profile that are characteristic of the onset of sepsis allows a clinician to diagnose the onset of sepsis from a bodily fluid isolated at the individual at a single point in time. The necessity of monitoring the patient over a period of time is, therefore, avoided, advantageously allowing clinical intervention before the onset of serious symptoms. Further, because the biomarker expression is assayed for its profile, identification of the particular biomarkers is unnecessary. The comparison of an individual's biomarker profile to biomarker profiles of appropriate reference populations likewise can be used to diagnose SIRS in the individual.

Diagnosis of sepsis or SIRS using biomarker profiles

Mass spectrometry techniques for determining the status of sepsis in an individual are provided. A biomarker profile resolved from a biological sample, taken from the individual, using a mass spectrometry technique is compared to a reference biomarker profile. A single such comparison classifies the individual as belonging to or not belonging to a reference population. The individual's biomarker profile and the reference biomarker profile comprise a plurality of ions each having a mass-to-charge ratio of about 100 Daltons to about 1000 Daltons. The plurality of ions can be detected by electrospray ionization mass spectrometry in positive mode. The comparison uses a decision rule, such as a classification tree, that determines the status of sepsis in the individual without requiring knowledge of the identity of the biomarkers in the biomarker profile from the individual and without requiring knowledge of the identity of the biomarkers in the reference biomarker profile.

Mass spectrometry techniques for determining the status of sepsis in an individual

Growing community of inventors

Glenville, PA, United States of America

Richard L Moore